Stock Research: Ono Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Ono Pharmaceutical

TSE:4528 JP3197600004
45
  • Value
    70
  • Growth
    14
  • Safety
    Safety
    90
  • Combined
    69
  • Sentiment
    27
  • 360° View
    360° View
    45
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company that manufactures and sells pharmaceuticals. The company operates in the pharmaceutical industry. ONO PHARMACEUTICAL CO., LTD. operates primarily in Japan. In the last fiscal year, the company had a market cap of $5,561 million, profits of $2,260 million, revenue of $3,247 million, and 4287 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 45 (better than 45% compared with alternatives), overall professional sentiment and financial characteristics for the stock Ono Pharmaceutical are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Ono Pharmaceutical. The consolidated Value Rank has an attractive rank of 90, which means that the share price of Ono Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 90% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 70. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 27. Professional investors are more confident in 73% other stocks. The consolidated Growth Rank also has a low rank of 14, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 86 of its competitors have better growth. ...read more

more
Index
TOPIX 100
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
90 94 84 65
Growth
14 22 11 57
Safety
Safety
70 95 90 82
Sentiment
27 6 32 31
360° View
360° View
45 61 55 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
3 1 5 41
Opinions Change
50 35 50 40
Pro Holdings
n/a 10 70 82
Market Pulse
68 46 44 12
Sentiment
27 6 32 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
90 94 84 65
Growth
14 22 11 57
Safety Safety
70 95 90 82
Combined
69 89 75 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
84 88 100 89
Price vs. Earnings (P/E)
55 69 41 39
Price vs. Book (P/B)
77 88 62 61
Dividend Yield
91 91 89 77
Value
90 94 84 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
7 41 10 76
Profit Growth
71 4 54 52
Capital Growth
13 79 32 17
Stock Returns
34 8 19 55
Growth
14 22 11 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
53 83 85 80
Refinancing
66 73 51 39
Liquidity
70 97 98 96
Safety Safety
70 95 90 82

Similar Stocks

Discover high‑ranked alternatives to Ono Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Megmilk Snow Brand

TSE:2270
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Tokuyama

TSE:4043
Country: Japan
Industry: Specialty Chemicals
Size: Medium
Full Stock Analysis

Tsumura

TSE:4540
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.